Reproductive Genetics Market Report by Product Type (Kits, Laboratory Developed Tests (LDT), Reagents and Consumables), Procedure Type (Carrier Screening, Pre-Natal Screening, Pre-Implantation Genetic Testing, Infertility Genetic Testing), Technology (Nex

Reproductive Genetics Market Report by Product Type (Kits, Laboratory Developed Tests (LDT), Reagents and Consumables), Procedure Type (Carrier Screening, Pre-Natal Screening, Pre-Implantation Genetic Testing, Infertility Genetic Testing), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization (ISH/FISH), Microarray), Application (Aneuploidy, Structural Chromosomal Abnormality, Single Gene Disorder, and Others), and Region 2024-2032


The global reproductive genetics market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.1 Billion by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:
The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global reproductive genetics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, procedure type, technology and application.

Product Type Insights:

Kits
Laboratory Developed Tests (LDT)
Reagents and Consumables

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the product type. This includes kits, laboratory developed tests (LDT), and reagents and consumables. According to the report, kits represented the largest segment.

Procedure Type Insights:

Carrier Screening
Pre-Natal Screening
Pre-Implantation Genetic Testing
Infertility Genetic Testing

A detailed breakup and analysis of the reproductive genetics market based on the procedure type has also been provided in the report. This includes carrier screening, pre-natal screening, pre-implantation genetic testing, and infertility genetic testing. According to the report, carrier screening accounted for the largest market share.

Technology Insights:

Next-Generation Sequencing
Polymerase Chain Reaction
In Situ Hybridization (ISH/FISH)
Microarray

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the technology. This includes next-generation sequencing, polymerase chain reaction, in situ hybridization (ISH/FISH), and microarray. According to the report, next-generation sequencing represented the largest segment.

Application Insights:

Aneuploidy
Structural Chromosomal Abnormality
Single Gene Disorder
Others

A detailed breakup and analysis of the reproductive genetics market based on the application has also been provided in the report. This includes aneuploidy, structural chromosomal abnormality, single gene disorder, and others. According to the report, aneuploidy accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global reproductive genetics market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global reproductive genetics market?
What is the impact of each driver, restraint, and opportunity on the global reproductive genetics market?
What are the key regional markets?
Which countries represent the most attractive reproductive genetics market?
What is the breakup of the market based on the product type?
Which is the most attractive product type in the reproductive genetics market?
What is the breakup of the market based on the procedure type?
Which is the most attractive procedure type in the reproductive genetics market?
What is the breakup of the market based on the technology?
Which is the most attractive technology in the reproductive genetics market?
What is the breakup of the market based on the application?
Which is the most attractive application in the reproductive genetics market?
What is the competitive structure of the global reproductive genetics market?
Who are the key players/companies in the global reproductive genetics market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Reproductive Genetics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Laboratory Developed Tests (LDT)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Reagents and Consumables
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Procedure Type
7.1 Carrier Screening
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pre-Natal Screening
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Pre-Implantation Genetic Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Infertility Genetic Testing
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Technology
8.1 Next-Generation Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Polymerase Chain Reaction
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 In Situ Hybridization (ISH/FISH)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Microarray
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Application
9.1 Aneuploidy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Structural Chromosomal Abnormality
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Single Gene Disorder
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bangkok Genomics Innovation Public Company Limited
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Centogene N.V.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Fulgent Genetics Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Igenomix (Vitrolife Group)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Invitae Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Laboratory Corporation of America Holdings
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 PerkinElmer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Thermo Fisher Scientific Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings